Topical application of dynorphin A (1-17) antibodies attenuates neuronal nitric oxide synthase up-regulation, edema formation, and cell injury following focal trauma to the rat spinal cord

Acta Neurochirurgica, Supplementum

Volumn , Issue 96, 2006, Pages 309-315

  Sharma, H S ^a   Nyberg, F ^b   Gordh, T ^a   Alm, P ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blood spinal cord barrier; Dynorphin A (1 17); nitric oxide synthase; spinal cord injury

Indexed keywords

ANTIBODY; DYNORPHIN; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; DRUG EFFECT; EDEMA; IMMUNOLOGY; MALE; RAT; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; ANTIBODIES; DYNORPHINS; EDEMA; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TREATMENT OUTCOME; UP-REGULATION;

EID: 85052608491     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-211-30714-1_66     Document Type: Article

References (40)

1. Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE (1997) Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765:283-290
2. Chavkin C, Goldstein A (1981) Specific receptors for the opioid peptide dynorphin: structure-activity relationships. Proc Natl Acad Sci USA 78:6543-6547
3. Chen L, Gu Y, Huang LY (1995) The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J Physiol 482:575-581
4. Cho HJ, Basbaum AI (1989) Ultratstructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat. J Comp Neurol 281:193-201
5. Faden AI (1990) Opioid and non-opioid mechanisms may contribute to dynorphin's pathophysiological actions in the spinal cord injury. Ann Neurol 27:64-74
6. Faden AI (1993) Role of endogenous opioids and opioid receptors in central nervous system injury. Handbook Exp Pharmacol 104, Part I: 325-341
7. Faden AI, Takemori AE, Portoghese PS (1987) Kappa-selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats. Cent Nerv Syst Trauma 4:227-237
8. Fallon JH, Ciofi P (1990) Dynorphin-containing neurons. Handbook Chem Neuroanat 9:1-286
9. Hauser KF, Knapp PE, Turbek CS (2001) Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites. Exp Neurol 168:78-87
10. Hu WH, Li F, Qiang WA, Liu N, Wang GQ, Xiao J, Liu JS, Liao WH, Jen MF (1999) Dual role for nitric oxide in dynorphin spinal neurotoxicity. J Neurotrauma 16:85-98
11. Hu WH, Qiang WA, Li F, Liu N, Wang GQ, Wang HY, Wan XS, Liao WH, Liu JS, Jen MF (2000) Constitutive and inducible nitric oxide synthases after dynorphin-induced spinal cord injury. J Chem Neuroanat 17:183-197
12. Isaac L, VanZandt O'Malley T, Ristic H, Stewart P (1990) MK-801 blocks dynorphin A (1-13)-induced loss of the tail-flick reflex in the rat. Brain Res 531:83-87
13. Long JB, Martinez-Arizala A, Echevarria EE, Tidwell RE, Holaday JW (1988) Hindlimb paralytic effects of prodynorphinderived peptides follwoing spinal subarachnoid injection in rats. Eur J Pharmacol 153:45-54
14. Long JB, Rigamonti DR, deCosta B, Rice KC, Martinez-Arizala A (1989) Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the K-opioid antagonist nor-binaltorphimine. Brain Res 497:155-162
15. Nichols ML, Lopez Y, Ossipov MH, Bian D, Porreca F (1997) Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphin by antisera to dynorphin A (1-13) or MK-801 in nerve-ligation model of peripheral neuropathy. Pain 69:317-322
16. Nyberg F, Sharma HS, Wiesenfeld-Hallin Z (1995) Neuropeptides in the spinal cord. Prog Brain Res 104:1-416
17. [131]I-sodium and lanthanum tracers. Acta Neurochir [Suppl] 76:159-163
18. Sharma HS (2003) Neurotrophic factors attenuate microvascular permeability disturbances and axonal injury following trauma to the rat spinal cord. Acta Neurochir [Suppl] 86:383-388
19. Sharma HS (2004) Pathophysiology of the blood-spinal cord barrier in traumatic injury. In: Sharma HS, Westman J (eds) Blood-spinal cord and brain barriers in health and disease. Elsevier Academic Press, San Diego, pp 437-518
20. Sharma HS (2005) Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des 11:1353-1389
21. Sharma HS (2005) Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury. An experimental study in the rat using pharmacological and morphological approaches. Ann NY Acad Sci [in press]
22. Sharma HS, Alm P (2002) Nitric oxide synthase inhibitors influence dynorphin A (1-17) immunoreactivity in the rat brain following hyperthermia. Amino Acids 23:247-259
23. Sharma HS, Alm P (2004) Role of nitric oxide on the bloodbrain and the spinal cord barriers. In: Sharma HS, Westman J (eds) Blood-spinal cord and brain barriers in health and disease. Elsevier Academic Press, San Diego, pp 191-230
24. Sharma HS, Nyberg F, Olsson Y, Dey PK (1990) Alteration in substance P in brain and spinal cord following spinal cord injury. An experimental study in the rat. Neuroscience 38:205-212
25. Sharma HS, Nyberg F, Olsson Y (1992) Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique. Neurosci Res 14:195-203
26. 7 in spinal cord and brain following traumatic injury of the spinal cord: influence of pchlorophenylalanine. An experimental study in the rat using radioimmunoassay technique. Neuropharmacology 32:711-717
27. Sharma HS, Nyberg F, Olsson Y (1994) Topical application of dynorphin antibodies reduces edema and cell changes in traumatized rat spinal cord. Regul Pept 1: S91-S92
28. Sharma HS, Olsson Y, Nyberg F (1995) Influence of dynorphin-A antibodies on the formation of edema and cell changes in spinal cord trauma. In: Nyberg F, Sharma HS, Wissenfeld-Hallin Z (eds) Neuropeptides in the spinal cord. Elsevier, Amsterdam, pp 401-416
29. Sharma HS, Westman J, Olsson Y, Alm P (1996) Involvement of nitric oxide in acute spinal cord injury: an immunohistochemical study using light and electron microscopy in the rat. Neurosci Res 24:373-384
30. Sharma HS, Westman J, Alm P, Sjöquist PO, Cervós-Navarro J, Nyberg F (1997) Involvement of nitric oxide in the pathophysiology of acute heat stress in the rat. Influence of a new antioxidant compound H-290/51. Ann NY Acad Sci 813:581-590
31. Sharma HS, Westman J, Nyberg F (1997) Topical application of 5-HT antibodies reduces edema and cell changes following trauma to the rat spinal cord. Acta Neurochir [Suppl] 70:155-158
32. Sharma HS, Westman J, Cervós-Navarro J, Dey PK, Nyberg F (1997) Opioid receptor antagonists attenuate heat stress-induced reduction in cerebral blood flow, increased blood-brain barrier permeability, vasogenic brain edema and cell changes in the rat. Ann NY Acad Sci 813:559-571
33. Sharma HS, Nyberg F, Gordh T, Alm P, Westman J (1997) Topical application of insulin like growth factor-1 reduces edema and upregulation of neuronal nitric oxide synthase following trauma to the rat spinal cord. Acta Neurochir [Suppl] 70:130-133
34. Sharma HS, Lundstedt T, Flärdh M, Westman J, Post C, Skottner A (2003) Low molecular weight compounds with affinity to melanocortin receptors exert neuroprotection in spinal cord injury - an experimental study in the rat. Acta Neurochir [Suppl] 86:399-405
35. Sharma HS, Sjöquist PO, Alm P (2003) A new antioxidant compound H-290/51 attenuates spinal cord injury induced expression of constitutive and inducible isoforms of nitric oxide synthase and edema formation in the rat. Acta Neurochir [Suppl] 86:415-420
36. Sharma HS, Badgaiyan RD, Mohanty S, Alm P, Wiklund L (2005) Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury induced pathophysiology and motor functions. An experimental study in the rat. Ann NY Acad Sci [in press]
37. Smith AP, Lee MN (1988) Pharmacology of dynorphin. Ann Rev Pharmacol Toxicol 28:123-140
38. Tang Q, Lynch RM, Porreca F, Lai J (2000) Dynorphin A elicits an increase inintracellular calcium in cultured neurons via a nonopioid, non-NMDA mechanims. J Neurophysiol 83:2610-2615
39. Winkler T, Sharma HS, Gordh T, Badgaiyan RD, Stålberg E, Westman J (2002) Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury. An experimental study in the rat using electrophysiological and morphological approaches. Amino Acids 23:273-281
40. Yakovlev AG, Faden AI (1994) Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol 23:179-190